Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
OBJECTIVE
The aim of this study was to compare the biological equivalent of low-dose-rate (LDR) and high-dose-rate (HDR) brachytherapy in terms of the more recent linear quadratic (LQ) model, which leads to theoretical estimation of biological equivalence.


METHODS
One of the key features of the LQ model is that it allows a more systematic radiobiological comparison between different types of treatment because the main parameters alpha/beta and micro are tissue-specific. Such comparisons also allow assessment of the likely change in the therapeutic ratio when switching between LDR and HDR treatments. The main application of LQ methodology, which focuses on by increasing the availability of remote afterloading units, has been to design fractionated HDR treatments that can replace existing LDR techniques.


RESULTS
In this study, with LDR treatments (39 Gy in 48 h) equivalent to 11 fractions of HDR irradiation at the experimental level, there are increasing reports of reproducible animal models that may be used to investigate the biological basis of brachytherapy and to help confirm theoretical predictions. This is a timely development owing to the nonavailability of sufficient retrospective patient data analysis.


CONCLUSIONS
It appears that HDR brachytherapy is likely to be a viable alternative to LDR only if it is delivered without a prohibitively large number of fractions (e.g., fewer than 11). With increased scientific understanding and technological capability, the prospect of a dose equivalent to HDR brachytherapy will allow greater utilization of the concepts discussed in this article.
Manimaran
S
S
Division of Physics, School of Science and Humanities, Vellore Institute of Technology, VIT University, Vellore 632 014, Tamil Nadu, India. manimaranq@hotmail.com
D001918:Brachytherapy / Q000379:methods*; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D016014:Linear Models; D009369:Neoplasms / Q000532:radiotherapy*; D011853:Radiobiology / Q000379:methods*; D011879:Radiotherapy Dosage; D012062:Relative Biological Effectiveness; D013997:Time Factors